Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001372514-25-000012
Filing Date
2025-03-25
Accepted
2025-03-25 06:55:58
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kprx-20241231.htm   iXBRL 10-K 1744234
2 EX-19.1 ex191-insidertradingpolicy.htm EX-19.1 39385
3 EX-23.1 ex231-20241231xkprx.htm EX-23.1 2968
4 EX-31.1 ex311-20241231xkprx.htm EX-31.1 8043
5 EX-31.2 ex312-20241231xkprx.htm EX-31.2 8020
6 EX-32.1 ex321-20241231xkprx.htm EX-32.1 4537
7 EX-32.2 ex322-20241231xkprx.htm EX-32.2 4525
8 EX-97.1 ex971-20241231xkprx.htm EX-97.1 29936
14 H&W LOGO hwlogo.jpg GRAPHIC 40816
15 PIPELINE kprx-20241231_g1.jpg GRAPHIC 82098
  Complete submission text file 0001372514-25-000012.txt   9994714

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20241231.xsd EX-101.SCH 72695
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20241231_cal.xml EX-101.CAL 104326
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20241231_def.xml EX-101.DEF 386662
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20241231_lab.xml EX-101.LAB 934517
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20241231_pre.xml EX-101.PRE 648745
100 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20241231_htm.xml XML 1154546
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36672 | Film No.: 25765785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)